Literature DB >> 12558864

Osteopontin is involved in the formation of epithelioid granuloma and bile duct injury in primary biliary cirrhosis.

Kenichi Harada1, Satoru Ozaki, Yoshiko Sudo, Koichi Tsuneyama, Hajime Ohta, Yasuni Nakanuma.   

Abstract

Recently, it was shown that osteopontin (OPN) is involved as a chemoattractant cytokine in the recruitment of macrophages and T lymphocytes in the granulomas of diverse etiologies and also plays an important role in the production of autoantibodies and development of autoimmune diseases. Primary biliary cirrhosis (PBC) is characterized by immune-mediated bile duct damage with frequent epithelioid granulomas. In this study, the expression of OPN was immunohistochemically examined in 25 PBC and 52 control livers. Epithelioid cells within granuloma in PBC expressed OPN variably. These cells were also positive for CD68, suggesting their histiocyte/macrophage lineage. In addition, strong expression of OPN was seen in the cytoplasm of mononuclear cells infiltrating around granulomas and also damaged bile ducts in PBC. The number of such positive mononuclear cells and the ratio of OPN-positive cells/total infiltrating cells in portal tracts were higher in PBC than in controls. The majority of these OPN-positive cells were found to be IgG- or IgM-producing plasma cells. These suggest that in PBC, OPN is an important immune molecule in portal tracts, and contributes to the recruitment of mononuclear cells into epithelioid granuloma and also participates in bile duct injury via B-cell differentiation and plasma cell expansion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12558864     DOI: 10.1046/j.1440-1827.2003.01426.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  12 in total

1.  Osteopontin expression in proliferated bile ductules: the correlation with liver damage in fulminant hepatitis.

Authors:  Takuma Tajiri; Genshu Tate; Toshiaki Kunimura; Yutaka Endo; Kazuaki Inoue; Toshiyuki Mitsuya; Toshio Morohoshi; Makoto Yoshiba
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

2.  Global gene expression profiling of dimethylnitrosamine-induced liver fibrosis: from pathological and biochemical data to microarray analysis.

Authors:  Li-Jen Su; Shih-Lan Hsu; Jyh-Shyue Yang; Huei-Hun Tseng; Shiu-Feng Huang; Chi-Ying F Huang
Journal:  Gene Expr       Date:  2006

Review 3.  Challenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesis.

Authors:  Fernando Bessone; Natalia Poles; Marcelo G Roma
Journal:  World J Hepatol       Date:  2014-06-27

4.  The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice.

Authors:  Peter Fickert; Andrea Thueringer; Tarek Moustafa; Dagmar Silbert; Judith Gumhold; Oleksiy Tsybrovskyy; Margitta Lebofsky; Hartmut Jaeschke; Helmut Denk; Michael Trauner
Journal:  Lab Invest       Date:  2010-04-05       Impact factor: 5.662

Review 5.  Concept on the pathogenesis and treatment of primary biliary cirrhosis.

Authors:  Vasiliy-Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

6.  Osteopontin upregulation in rotavirus-induced murine biliary atresia requires replicating virus but is not necessary for development of biliary atresia.

Authors:  Paula M Hertel; Sue E Crawford; Milton J Finegold; Mary K Estes
Journal:  Virology       Date:  2011-07-13       Impact factor: 3.616

7.  Osteopontin Expression in Patients with Hepatolith.

Authors:  Bum Soo Kim; Sun Hyung Joo; Sung Jig Lim; Kwang Ro Joo
Journal:  Indian J Surg       Date:  2013-05-18       Impact factor: 0.656

Review 8.  Clinical Characteristics of Concomitant Systemic Lupus Erythematosus and Primary Biliary Cirrhosis: A Literature Review.

Authors:  Toru Shizuma
Journal:  J Immunol Res       Date:  2015-05-18       Impact factor: 4.818

9.  Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans.

Authors:  James Pritchett; Emma Harvey; Varinder Athwal; Andrew Berry; Cliff Rowe; Fiona Oakley; Anna Moles; Derek A Mann; Nicoletta Bobola; Andrew D Sharrocks; Brian J Thomson; Abed M Zaitoun; William L Irving; Indra N Guha; Neil A Hanley; Karen Piper Hanley
Journal:  Hepatology       Date:  2012-09       Impact factor: 17.425

10.  Late-onset systemic lupus erythematosus-associated primary biliary cirrhosis.

Authors:  Sonia Hammami; Nabil Chaabane; Houda Mahmoudi; Fethia Bdioui; Hamouda Saffar
Journal:  Int Arch Med       Date:  2013-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.